CAS |
10236-47-2 |
Chinese Name |
柚皮苷 |
English Name |
Naringin |
Synonym |
柚皮苷;柚苷;柑橘甙;异橙皮甙; |
Unit |
Bottle |
Purity |
HPLC≥98% |
Molecular Formula |
C27H32O14 |
Molecular Weight |
580.53 |
Appearance |
White to yellow solid |
Storage |
Powder : 2-8℃, 2 years; In solvent(mother liquid): -20℃, 1 month; -80℃, 6 months |
Solubility |
Soluble in DMSO≥10mg/ml, soluble in water<1mg/ml |
EC |
EINECS 233-566-4 |
MDL |
MFCD00148888 |
InChIKey |
DFPMSGMNTNDNHN-ZPHOTFPESA-N |
InChI |
InChI=1S/C27H32O14/c1-10-20(32)22(34)24(36)26(37-10)41-25-23(35)21(33)18(9-28)40-27(25)38-13-6-14(30)19-15(31)8-16(39-17(19)7-13)11-2-4-12(29)5-3-11/h2-7,10,16,18,20-30,32-36H,8-9H2,1H3/t10-,16-,18+,20-,21+,22+,23-,24+,25+,26-,27+/m0/s1 |
PubChem CID |
442428 |
SMILES |
O=C1C[C@@H](C2=CC=C(O)C=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O[C@@]5([H])[C@@H]([C@@H]([C@H]([C@H](C)O5)O)O)O)=CC(O)=C13 |
Description |
Naringin is a flavanone glycoside with many biological activities, which can be used for researches on antioxidant activity, blood lipid lowering, anticancer, and inhibition of cytochrome P450 enzymes. |
Target Point |
Cytochrome P450 |
Passage |
Metabolic Enzyme&Protease |
IC50 |
IC50: 9026 uM (p450) [1-4] |
Data Literature Source |
[1]. Chen F, et al. Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction. PLoS One. 2015 Nov 30; 10 (11) :e0143868.
[2]. Raha S, et al. Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells. Int J Oncol. 2015 Sep; 47 (3) :1061-9.
[3]. Kulasekaran G, et al. Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells. Mol Cell Biochem. 2015 Nov; 409 (1-2) :199-211.
[4]. Wang D, et al. Naringin Improves Neuronal Insulin Signaling, Brain Mitochondrial Function, and Cognitive Function in High-Fat Diet-Induced Obese Mice. Cell Mol Neurobiol. 2015 Oct; 35 (7) :1061-71 |
Specification |
10mg 50mg 10mM*1mL (in DMSO) |